WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-17 Cr | ₹-8.84 Cr | ₹0.59 Cr | ₹8.04 Cr | ₹64 Cr |
What is the latest Cash Flow from Investing Activities ratio of WANBURY ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-17 Cr |
Mar2023 | ₹-8.84 Cr |
Mar2022 | ₹0.59 Cr |
Mar2021 | ₹8.04 Cr |
Mar2020 | ₹64 Cr |
How is Cash Flow from Investing Activities of WANBURY Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-17 Cr | Negative | |
Mar2023 | ₹-8.84 Cr | Negative | |
Mar2022 | ₹0.59 Cr | -92.70 | |
Mar2021 | ₹8.04 Cr | -87.36 | |
Mar2020 | ₹64 Cr | - |
Compare Cash Flow from Investing Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹829.2 Cr | -1.1% | -6.8% | 36.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -1.1% |
-6.8% |
36.1% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses